ChemoMetec Statistics
Total Valuation
ChemoMetec has a market cap or net worth of DKK 8.54 billion. The enterprise value is 8.25 billion.
Market Cap | 8.54B |
Enterprise Value | 8.25B |
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025.
Earnings Date | Feb 5, 2025 |
Ex-Dividend Date | Oct 11, 2024 |
Share Statistics
ChemoMetec has 17.40 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 17.40M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.22% |
Owned by Insiders (%) | 0.36% |
Owned by Institutions (%) | 50.65% |
Float | 17.34M |
Valuation Ratios
The trailing PE ratio is 62.71 and the forward PE ratio is 46.54. ChemoMetec's PEG ratio is 9.50.
PE Ratio | 62.71 |
Forward PE | 46.54 |
PS Ratio | 20.95 |
PB Ratio | 15.11 |
P/TBV Ratio | 18.15 |
P/FCF Ratio | 79.08 |
P/OCF Ratio | n/a |
PEG Ratio | 9.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.16, with an EV/FCF ratio of 76.37.
EV / Earnings | 60.55 |
EV / Sales | 20.23 |
EV / EBITDA | 46.16 |
EV / EBIT | 48.84 |
EV / FCF | 76.37 |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.01.
Current Ratio | 4.97 |
Quick Ratio | 3.71 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.02 |
Debt / FCF | 0.04 |
Interest Coverage | 923.31 |
Financial Efficiency
Return on equity (ROE) is 24.82% and return on invested capital (ROIC) is 19.03%.
Return on Equity (ROE) | 24.82% |
Return on Assets (ROA) | 15.82% |
Return on Capital (ROIC) | 19.03% |
Revenue Per Employee | 2.34M |
Profits Per Employee | 783,241 |
Employee Count | 174 |
Asset Turnover | 0.61 |
Inventory Turnover | 0.35 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.24% in the last 52 weeks. The beta is 1.31, so ChemoMetec's price volatility has been higher than the market average.
Beta (5Y) | 1.31 |
52-Week Price Change | +16.24% |
50-Day Moving Average | 449.47 |
200-Day Moving Average | 389.14 |
Relative Strength Index (RSI) | 56.44 |
Average Volume (20 Days) | 40,733 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ChemoMetec had revenue of DKK 407.87 million and earned 136.28 million in profits. Earnings per share was 7.83.
Revenue | 407.87M |
Gross Profit | 367.60M |
Operating Income | 168.97M |
Pretax Income | 176.59M |
Net Income | 136.28M |
EBITDA | 178.78M |
EBIT | 168.97M |
Earnings Per Share (EPS) | 7.83 |
Balance Sheet
The company has 296.15 million in cash and 4.16 million in debt, giving a net cash position of 291.99 million or 16.78 per share.
Cash & Cash Equivalents | 296.15M |
Total Debt | 4.16M |
Net Cash | 291.99M |
Net Cash Per Share | 16.78 |
Equity (Book Value) | 565.32M |
Book Value Per Share | 32.48 |
Working Capital | 391.27M |
Cash Flow
In the last 12 months, operating cash flow was 129.00 million and capital expenditures -20.95 million, giving a free cash flow of 108.06 million.
Operating Cash Flow | 129.00M |
Capital Expenditures | -20.95M |
Free Cash Flow | 108.06M |
FCF Per Share | 6.21 |
Margins
Gross margin is 90.13%, with operating and profit margins of 41.43% and 33.41%.
Gross Margin | 90.13% |
Operating Margin | 41.43% |
Pretax Margin | 43.29% |
Profit Margin | 33.41% |
EBITDA Margin | 43.83% |
EBIT Margin | 41.43% |
FCF Margin | 26.49% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.81%.
Dividend Per Share | 4.00 |
Dividend Yield | 0.81% |
Dividend Growth (YoY) | -33.33% |
Years of Dividend Growth | 1 |
Payout Ratio | 76.62% |
Buyback Yield | n/a |
Shareholder Yield | 0.81% |
Earnings Yield | 1.59% |
FCF Yield | 1.26% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ChemoMetec has an Altman Z-Score of 38.72.
Altman Z-Score | 38.72 |
Piotroski F-Score | n/a |